JP2023535232A5 - - Google Patents
Info
- Publication number
- JP2023535232A5 JP2023535232A5 JP2023512465A JP2023512465A JP2023535232A5 JP 2023535232 A5 JP2023535232 A5 JP 2023535232A5 JP 2023512465 A JP2023512465 A JP 2023512465A JP 2023512465 A JP2023512465 A JP 2023512465A JP 2023535232 A5 JP2023535232 A5 JP 2023535232A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- promoter
- sequence
- nos
- rpe65
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010704946.1 | 2020-07-21 | ||
| CN202010704946.1A CN113952471A (zh) | 2020-07-21 | 2020-07-21 | 用于治疗眼部疾病的组合物和方法 |
| CN202110378979 | 2021-04-08 | ||
| CN202110378979.6 | 2021-04-08 | ||
| PCT/CN2021/107284 WO2022017363A1 (en) | 2020-07-21 | 2021-07-20 | Compositions and methods for the treatment of ocular diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023535232A JP2023535232A (ja) | 2023-08-16 |
| JP2023535232A5 true JP2023535232A5 (https=) | 2024-07-26 |
Family
ID=79728991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512465A Withdrawn JP2023535232A (ja) | 2020-07-21 | 2021-07-20 | 眼疾患の処置のための組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230321280A1 (https=) |
| EP (1) | EP4185335A1 (https=) |
| JP (1) | JP2023535232A (https=) |
| CN (1) | CN116368228A (https=) |
| AU (1) | AU2021314400A1 (https=) |
| CA (1) | CA3186818A1 (https=) |
| WO (1) | WO2022017363A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250295808A1 (en) * | 2022-03-28 | 2025-09-25 | Indian Institute Of Technology Kanpur | A system for an ocular gene therapy and a process for preparing thereof |
| WO2024077089A2 (en) * | 2022-10-04 | 2024-04-11 | Siren Biotechnology, Inc. | Modified cpg dinucleotides for recombinant viral vector production |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201502137D0 (en) * | 2015-02-09 | 2015-03-25 | Ucl Business Plc | Treatment |
| HK1253299A1 (zh) * | 2015-06-04 | 2019-06-14 | INSERM (Institut National de la Santé et de la Recherche Médicale) | 一种通过基因治疗治疗眼疾病的改进方法 |
| SG11202000840YA (en) * | 2017-07-31 | 2020-02-27 | Reflection Biotechnologies Ltd | Cellular models of and therapies for ocular diseases |
| CN111118017B (zh) * | 2018-11-01 | 2023-10-03 | 上海朗昇生物科技有限公司 | 治疗Leber先天性黑蒙症的载体及其应用 |
-
2021
- 2021-07-20 WO PCT/CN2021/107284 patent/WO2022017363A1/en not_active Ceased
- 2021-07-20 JP JP2023512465A patent/JP2023535232A/ja not_active Withdrawn
- 2021-07-20 EP EP21846029.3A patent/EP4185335A1/en not_active Withdrawn
- 2021-07-20 CA CA3186818A patent/CA3186818A1/en active Pending
- 2021-07-20 AU AU2021314400A patent/AU2021314400A1/en not_active Abandoned
- 2021-07-20 CN CN202180064406.4A patent/CN116368228A/zh active Pending
-
2023
- 2023-01-20 US US18/157,577 patent/US20230321280A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230414724A1 (en) | Treatment of hyperbilirubinemia | |
| JP2022500066A5 (https=) | ||
| JP2023532663A5 (https=) | ||
| JP2023070682A5 (https=) | ||
| JP2020520662A5 (https=) | ||
| EP3470523A1 (en) | Adeno associated virus plasmids and vectors | |
| JP2023515072A5 (https=) | ||
| JP2022106918A5 (https=) | ||
| JP2023535232A5 (https=) | ||
| JP2020518268A5 (https=) | ||
| JP7558535B2 (ja) | アルデヒドデヒドロゲナーゼ欠損症の治療のための遺伝子治療 | |
| CN106794262A (zh) | 哺乳动物rpe65的高异构水解酶活性突变体 | |
| JP2021500922A5 (https=) | ||
| JP2019524090A5 (https=) | ||
| JP2022553573A5 (https=) | ||
| EP3870237A1 (en) | Liver-specific nucleic acid regulatory elements and methods and use thereof | |
| JP2020512822A5 (https=) | ||
| JP2021500070A5 (https=) | ||
| JP2023540464A5 (https=) | ||
| JP2022539156A (ja) | ヒアルロン酸を用いた眼組織へのａａｖ媒介形質導入の増強 | |
| JP2023509443A5 (https=) | ||
| JP2024545183A5 (https=) | ||
| JP2021525531A5 (https=) | ||
| JP2021512871A5 (https=) | ||
| JP2018509154A5 (https=) |